Accent Microcell
NSE: ACCENTMIC · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Accent Microcell's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Accent Microcell Ltd is a manufacturer and exporter specialising in pharmaceutical excipients, specifically Microcrystalline Cellulose (MCC). The company produces 22 different grades of MCC, serving over 200 customers across 10 diverse industrial sectors.
Business Model
The company generates revenue through the manufacturing and sale of high-quality excipients that meet international certifications such as US-DMF, EXCiPACT, and GMP. It leverages its technical certifications to supply both domestic and international markets.
- MCC Grades:22
- Customer Base:200+
- Sectors Served:10+
Growth Outlook
Growth is expected to be driven by the company's established international certifications, which facilitate expansion into regulated global pharmaceutical markets. Continued demand for high-quality excipients across its diverse customer base supports long-term scaling.
Key Risks
- Regulatory Compliance. Failure to maintain international certifications like US-DMF and GMP could restrict access to key export markets.
- Raw Material Volatility. Fluctuations in the cost of raw materials used in the production of cellulose can impact profit margins.
- Market Competition. The pharmaceutical excipient industry is highly competitive, potentially leading to pricing pressures from global manufacturers.
Start your research today
Unlock AI insights, financials, peers and live data on Accent Microcell and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Accent MicrocellACCENTMIC | ₹1,608 Cr | — | — | — | 16.0% | — | — | +171.8% |
NGL Fine ChemNGLFINE | ₹1,749 Cr | 35.82 | 21.06 | — | 16.8% | 15.8% | 18.4% | +103.4% |
Anlon HealthcareAHCL | ₹1,578 Cr | 5.88 | 33.92 | — | 27.4% | 13.9% | 21.3% | -74.7% |
Jagsonpal Pharmaceuticals LimitedJAGSNPHARM | ₹1,485 Cr | 34.08 | 20.18 | 3.9% | 24.9% | 17.6% | 22.9% | +4.2% |
Amrutanjan Health Care LimitedAMRUTANJAN | ₹1,475 Cr | 27.49 | 16.18 | 10.7% | 17.7% | 15.5% | 20.2% | -28.1% |
Fermenta Biotec.FERMENTA | ₹1,399 Cr | 26.47 | 13.72 | -3.2% | 21.1% | 15.2% | 22.2% | +70.5% |
As of Mar 2026
Financials
Accent Microcell
NSE: ACCENTMIC · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Accent Microcell's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Accent Microcell Ltd is a manufacturer and exporter specialising in pharmaceutical excipients, specifically Microcrystalline Cellulose (MCC). The company produces 22 different grades of MCC, serving over 200 customers across 10 diverse industrial sectors.
Business Model
The company generates revenue through the manufacturing and sale of high-quality excipients that meet international certifications such as US-DMF, EXCiPACT, and GMP. It leverages its technical certifications to supply both domestic and international markets.
- MCC Grades:22
- Customer Base:200+
- Sectors Served:10+
Growth Outlook
Growth is expected to be driven by the company's established international certifications, which facilitate expansion into regulated global pharmaceutical markets. Continued demand for high-quality excipients across its diverse customer base supports long-term scaling.
Key Risks
- Regulatory Compliance. Failure to maintain international certifications like US-DMF and GMP could restrict access to key export markets.
- Raw Material Volatility. Fluctuations in the cost of raw materials used in the production of cellulose can impact profit margins.
- Market Competition. The pharmaceutical excipient industry is highly competitive, potentially leading to pricing pressures from global manufacturers.
Start your research today
Unlock AI insights, financials, peers and live data on Accent Microcell and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026